NEW BRUNSWICK, N.J., Nov. 1 /PRNewswire/ -- Executive pharmaceutical marketing management faces a gauntlet of challenges and opportunities in 2006 as the industry continues to re-organize itself around new developments, some of which are of great concern for the marketing and sales engines that drive their growth. The 4th Annual Pharmaceutical Marketing & Sales World Summit will take place to address and present these concerns on April 4-5, 2006 in New Brunswick, NJ, reports Strategic Research Institute.
The annual conference is expected to draw 500 attendees from around the industry, especially from the larger and mid-sized pharmaceutical companies. The conference provides presenters a once a year chance to present new findings and meet counterparts as part of an information and networking extravaganza.
Lower revenue niche products are one development that has affected the face of marketing and sales, as has the Medicare Modernization Act, an increased regulatory scrutiny. The industry seems poised for the introduction of a new round of new drugs and potential blockbusters.
The mega-event offers unprecedented value to its attendees by tracking the meeting along six related and concurrent themes, all oriented to provide the vital information industry marketers demand to re-think and enhance their brand’s performances in the US market and abroad. Attendees may register for any of the six meetings and attend sessions from the menu of sessions taking place at any time.
In addition, frequent networking sessions for all attendees, speakers, sponsors, and exhibitors are coordinated to bring everyone together. Themed nightly functions are also offered to encourage and facilitate attendee socialization.
The six, concurrent conferences with shared socializing events under the
PMS banner are:
Brand Management Managed Care Marketing/Medicare Sales/Detailing/eDetailing OIG Compliance for Marketers Patient Level Data Compliance & Persistency
The unprecedented level of valuable information and networking meets the needs of all participants. The organizers look forward to unveiling the agenda in several weeks and to the spectacularly successful event that will take place in April.
Speaking slots still remain and proposals may be submitted through Friday, November 4. Submissions should be titled and 50-100 words and sent to Mark Alexay, Executive Vice President, Life Sciences, Strategic Research Institute at malexay@srinstitute.com. All constituents in the industry, though especially from pharmaceutical companies, are encouraged to submit proposals. Panel topics may be suggested as well.
Prime sponsorship opportunities and exhibit space still remain. Space continues to be assigned on a first-come, first-serve basis and sponsorship with speaking opportunities are especially in short supply. Contact Mark Alexay at malexay@srinstitute.com or 201.452.4023 to decide what level of participation works best.
Contact: Mark Alexay 201.452.4023
Strategic Research Institute
CONTACT: Mark Alexay of Strategic Research Institute, +1-201-452-4023
Web site: http://www.srinstitute.com/
